Olmesartan/amlodipine vs olmesartan/hydrochlorothiazide in hypertensive patients with metabolic syndrome: the OLAS study

We studied the effects of treatment with olmesartan/amlodipine and olmesartan/hydrochlorothiazide on inflammatory and metabolic parameters (including new-onset diabetes as a secondary endpoint) in non-diabetic hypertensive patients with metabolic syndrome (MetS). A total of 120 patients with MetS an...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Martinez-Martin, F J, Rodriguez-Rosas, H, Peiro-Martinez, I, Soriano-Perera, P, Pedrianes-Martin, P, Comi-Diaz, C
Formato: Artigo
Lenguaje:Inglês
Publicado: Nature Publishing Group 2011
Materias:
Original Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC3099035/
https://ncbi.nlm.nih.gov/pubmed/21107432
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/jhh.2010.104
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares